Filter
462
Filtered Results: 462
Text search:
schizofrenia
Featured
Recommendations
47
New Publications
63
Language
Document type
No document type
361
Studies & Reports
32
Guidelines
21
Training Material
16
Manuals
12
Strategic & Response Plan
9
Fact sheets
9
Brochures
1
Resource Platforms
1
Countries / Regions
India
17
South Africa
15
Western and Central Europe
14
Ethiopia
13
Global
10
Eastern Europe
10
Kenya
8
Latin America and the Carribbean
8
Russia
8
Ukraine
6
Ghana
6
Bangladesh
6
Sierra Leone
5
Nigeria
5
Lesotho
4
Syria
4
Uganda
4
Zambia
4
Nepal
3
Canada
3
Malawi
3
Cambodia
3
Tanzania
3
Namibia
3
Indonesia
3
Iraq
3
Liberia
3
China
2
Afghanistan
2
Mozambique
2
Africa
2
Asia
2
Jamaica
2
United Kingdom
2
Sri Lanka
2
Mexico
1
Turkey
1
Rwanda
1
Kazakhstan
1
Cameroon
1
Iran
1
Laos
1
Estonia
1
Burkina Faso
1
Peru
1
Zimbabwe
1
Bulgaria
1
Philippines
1
USA
1
Haiti
1
Venezuela
1
Lithuania
1
Jordan
1
Ireland
1
South–East Asia Region
1
Paraguay
1
Lebanon
1
Brazil
1
Sudan
1
Yemen
1
Palestine
1
Botswana
1
South Sudan
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
102
Public Health
12
Clinical Guidelines
8
Women & Child Health
3
Key Resources
3
Capacity Building
2
Pharmacy & Technologies
1
Toolboxes
Mental Health
324
Disability
39
Conflict
9
Pharmacy
6
Refugee
5
COVID-19
5
HIV
4
Planetary Health
4
Global Health Education
4
Caregiver
3
NCDs
3
TB
2
Ebola & Marburg
2
NTDs
2
Natural Hazards
1
Social Ethics
1
Zika
1
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)...
This Practice Parameter reviews the evidence from research and clinical experience and highlights significant advances in the assessment and treatment of posttraumatic stress disorder since the previous Parameter was published in 1998. It highlights the importance of early identification of posttrau...
PLoS Med 10(1): e1001366. https://doi.org/10.1371/journal.pmed.1001366
Published: January 8, 2013
Guiding framework for development cooperation, Working paper 2017.
This document was drawn up on the basis of expert publications and inputs from partners in the
GIZ regional programme Psychosocial Support for Syrian and Iraqi Refugees and Internally
Displaced People1 in order to serve as guidanc...
Petersenet al.International Journal of Mental Health Systems2011,5:8http://www.ijmhs.com/content/5/1/8
Paediatrics
Chapter I.2
Introduction
Chapter A.5
A Global Perspective
Global Campaign Against Epilepsy
Introduction
Chapitre A.6
Edition en français Traduction : Cristina Constantin Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA
World J Meta-Anal. Aug 26, 2017; 5(4): 103-123
Published online Aug 26, 2017. doi: 10.13105/wjma.v5.i4.103
In the last quarter century, several projects emerged to reform mental health services in Latin American and Caribbean countries. Some did not survive the difficulties that inevitably arise in processes of change, and ended up disappearing before the intended changes could be introduced. Others, how...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
World Psychiatry. 2010 Jun;9(2):67-77.
The main recommendations are presented in relation to: the need for coordinated policies, plans and programmes, the requirement to scale up services for whole populations, the importance of promoting community awareness about mental illness to increase levels ...
Q9: Antidepressant medicines in individuals with a depressive episode in bipolar disorder1Q9: In individuals presenting with a depressive episode in bipolar disorder, are antidepressant medicines effective and safe?
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
Introduction
Chapter A.6
